NATALIE WADE: Open Payments
NPI 1245015213 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 37 payments from 12 companies in 2025. Trend: 2023 $236 · 2024 $1,623 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $210 |
| Novartis Pharmaceuticals Corporation | 8 | $179 |
| Galderma Laboratories, L.P. | 3 | $138 |
| Janssen Scientific Affairs, LLC | 1 | $110 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| GENZYME CORPORATION | 2 | $65 |
| UCB, Inc. | 2 | $36 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: COSENTYX, NEMLUVIO, TREMFYA, SKYRIZI, RINVOQ, ILUMYA, DUPIXENT, Bimzelx.
Industry payments across AZ — which companies pay providers there.
